首页> 外文期刊>Obstetrical and gynecological survey >Dehydroepiandrosterone (DHEA), DHEA Sulfate, and Aging: Contribution of the DHEAge Study to a Sociobiomedical Issue
【24h】

Dehydroepiandrosterone (DHEA), DHEA Sulfate, and Aging: Contribution of the DHEAge Study to a Sociobiomedical Issue

机译:脱氢表雄酮 (DHEA)、硫酸脱氢表雄酮和衰老和结肠; DHEAge 研究对社会生物医学问题的贡献

获取原文
获取外文期刊封面目录资料

摘要

Studies showing that blood levels of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) drop markedly with advancing age led to the concept of an “adrenopause” that might conceivably impair health. One implication is that administering DHEA may confer benefit, as does administration of estrogen to postmenopausal women. Wide interest in this possibility promoted a randomized, double-blind, placebo-controlled, year-long trial of orally administered DHEA in 280 men and women aged 60 to 79 years, the DHEAge Study. Participants were seen for various reasons at a geriatric clinic but had no severe or evolving disease. Subjects took 50 mg of DHEA daily or a placebo for 1 year and were followed up at 3-month intervals.Young adult DHEAS levels were present in men after 6 months of receiving DHEA. After 1 year of treatment the levels fell significantly compared with 6-month values in men less than 70 years of age but not in older men. Estradiol levels increased significantly during the treatment year. Women had higher DHEAS levels after 6 months of treatment, exceeding young adult values, but nearly all of them had a secondary reduction after 1 year of treatment, and this was highly significant in those younger than 70 years. There were no changes in levels of gonadotropins, thyrotropin, or triiodothyronine. Testosterone levels increased to a limited extent. Bone turnover, as measured by dual-energy x-ray absorptiometry, improved in women older than 70 years. Older women also had significantly increased libido, and skin hydration improved at the same time. In addition, pigmentation of the facial skin decreased significantly, sebum production increased, and epidermal thickness was greater than in placebo recipients.Treatment for 1 year with 50 mg daily of DHEA seems to normalize some of the effects of aging without obvious harmful consequences. It does not, however, in any sense create “supermen” or “superwomen.” Those who take DHEA at this dose level, or even in smaller amounts, require appropriate follow-up at reasonable intervals.Proc Natl Acad Sci U S A 2000;97:4279–4284
机译:研究表明,血液中脱氢表雄酮(DHEA)及其硫酸酯(DHEAS)的水平随着年龄的增长而显着下降,这导致了“肾上腺上腺素更年期”的概念,这可能会损害健康。一种含义是,给予 DHEA 可能会带来益处,绝经后妇女服用雌激素也是如此。对这种可能性的广泛兴趣促进了一项为期一年的随机、双盲、安慰剂对照、对 280 名 60 至 79 岁的男性和女性口服 DHEA 试验,即 DHEAge 研究。受试者因各种原因在老年诊所就诊,但没有严重或进展的疾病。受试者每天服用 50 毫克 DHEA 或安慰剂,持续 1 年,并每隔 3 个月随访一次。接受 DHEA 治疗 6 个月后,男性的年轻成人 DHEAS 水平出现。治疗 1 年后,与 6 个月值相比,70 岁以下男性的水平显着下降,但老年男性没有。雌二醇水平在治疗期间显着增加。女性在治疗 6 个月后 DHEAS 水平较高,超过了年轻成人值,但几乎所有女性在治疗 1 年后都有继发性降低,这在 70 岁以下的女性中非常显着。促性腺激素、促甲状腺激素或三碘甲状腺原氨酸水平没有变化。睾酮水平在一定程度上增加。通过双能 X 射线吸收测定法测量的骨转换率在 70 岁以上的女性中有所改善。老年女性的也显着增加,同时皮肤水合作用得到改善。此外,面部皮肤的色素沉着显着减少,皮脂产生增加,表皮厚度大于安慰剂接受者。每天服用 50 毫克 DHEA 治疗 1 年似乎可以使衰老的一些影响正常化,而不会产生明显的有害后果。然而,它并没有在任何意义上创造“超人”或“女超人”。以这种剂量水平甚至较小量服用 DHEA 的人需要在合理的时间间隔进行适当的随访。美国国家科学院院刊 2000;97&冒号;4279–4284
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号